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Background: Adherence to self-management in asthma is poor. Aim: To investigate the
effect of disease-unspeciﬁc motivational training on self-management adherence in addi-
tion to asthma-speciﬁc patient education. Methods: We randomized patients with partly
controlled asthma to asthma education, with or without the Zurich Resource Model (ZRM)
training. Main elements of the ZRM training are development of action-oriented personal
goals and activation of resources to achieve and practice them in daily life. The primary
outcome was adherence to self-monitoring and to a written personal action plan during
three months. Secondary outcomes included patient-reported self-efﬁcacy. Results: As
control patients (n=30) were younger, mostly male and had better asthma control com-
pared with the intervention group (n=30), we adjusted the analyses for these imbalances.
Both groups showed excellent adherence to self-monitoring over threemonths [27 patients
(90.0%) in intervention and 25 patients (83.3%) in control group, adjusted odds ratio: 1.28
(0.24–6.78), P=0.78)]. Patients in the ZRM group tended to adjust their medication more
often [median 36%dayswith action (IQR11–62%)] than control patients [9% (0–43),P=0.18].
In both groups, actions were rarely in accordance with the action plan [median 20% of
actions appropriate (IQR 0–37) in intervention and 11% (IQR 0–56) in control group, P=0.92].
After three months, self-efﬁcacy was signiﬁcantly better with ZRM (adjusted difference on
self-efﬁcacy scale 2.31, 95%CI 0.31–4.31, P=0.02).Conclusion:Unspeciﬁc self-management
training had no short-term effect on self-management adherence in asthma patients. Self-
efﬁcacy improved, but it is uncertainwhether this translates into better long-termoutcomes.
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Introduction
Education in self-management is a cornerstone in
asthma management (National Heart Lung and
Blood Institute, 1991; The British Thoracic
Society, 2003). Strong evidence exists that self-
management with an action plan reduces hospital
admissions, emergency visits, and time off work or
school (Gibson et al., 2003; Gibson and Powell,
2004).
Despite the evidence supporting asthma self-
management, adherence to self-monitoring and an
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action plan in daily practice is low (Jones et al., 2000).
Known explanations are that most asthma educa-
tion programmes simply provide information
without supporting the patients’ inner motivation
to be in control of their asthma or without
explaining the benefits of self-monitoring and of
an action plan. In addition, there is often insuf-
ficient coaching of patients in the proper use of
an action plan so that they would feel more
confident and safe in using it (Jones et al., 2000;
Clark and Partridge, 2002; Partridge et al., 2006;
Steurer-Stey et al., 2006). A further important
reason for non-adherence to action plans is that
relevant psychosocial and behavioural principles
associated with improved adherence such as
self-regulation and self-efficacy receive little
consideration in daily practice (Bandura, 1977a;
1997; Clark et al., 2001). According to Bandura’s
social cognitive theory, an individual’s percep-
tion of his or her ability to perform an action
(self-efficacy) and his or her expectations that the
behaviour will have desirable result are important
mediators of performance (Bandura, 1977b; 1997;
2001). Evidence suggests that self-efficacy is a
critical ingredient in the self-management process
and for better health outcomes (Holman and
Lorig, 1992; Lorig et al., 2001b; Barlow et al., 2002;
Bodenheimer et al., 2002; Clark and Partridge,
2002; Calfee et al., 2006).
However, the extent to which patients acquire
and apply self-management does not primarily
depend on their knowledge of the disease but on a
range of individual and non-disease-related
factors, processes and resources. A key to suc-
cessful patient self-management is to align their
thoughts, feelings and behaviours with their
treatment goals. We hypothesized that a well-
established resource-activating training, which is
not disease-specific, could improve the ability
of asthma patients to adopt successful asthma
self-management. We used the Zurich Resource
Model (ZRM) training, which is based on
cognitive-behavioural theory and supports people
to define their intentions and actions to realize
their goals in daily life (Storch and Krause, 2002;
Storch, 2004) We studied in a randomized con-
trolled trial whether the resource-activating ZRM
training increases self-efficacy and improves
asthma-specific self-management when added to a
asthma-specific patient education programme in
patients with partially controlled asthma.
Methods
Study design and patient recruitment
We conducted a randomized clinical trial com-
paring asthma-speciﬁc patient education with and
without non-speciﬁc disease self-management
training. We included patients who were 18 years
and older with partially controlled asthma, according
to Global Initiative for Asthma (GINA) guidelines
(GINA, 2006) (symptoms during day, or night time,
limitation in daily activities or sports because of
asthma, need for rescue medication or unscheduled
visits to the treating physician, emergency depart-
ment visits because of exacerbations in the last six
months). Asthma was deﬁned by history, symptoms
and criteria for reversibility with FEV1 increase of
more than 12% and 200ml after bronchodilatation
(GINA, 2006). We excluded patients with a psy-
chiatric diagnosis such as major depression, schi-
zophrenia, substance abuse or personality
disorders, patients with other lung diseases, and
patients with insufﬁcient knowledge of the German
language to follow the training and/or to complete
questionnaires. Between October and December
2007, we identiﬁed potentially eligible patients from
the outpatient clinic and emergency room of the
University Hospital of Zurich and from referrals from
general and chest physicians in the Canton of Zurich.
Eligible patients willing to participate were informed
about the study orally and in writing and asked for
informed consent. We obtained approval from the
local ethics committee and registered the trial in the
International Standard Randomized Controlled Trial
Number register (ISRCTN 33589847).
Randomization and concealment of random
allocation
Weused STATA software (STATA forWindows
version 8.2, StataCorp, College Station, TX,USA) to
generate the randomization list (ralloc command)
with stratiﬁcation for duration of illness (time since
diagnosis<5 years or ⩾5 years) and age (<30 years
or ⩾30 years). The randomization list was kept con-
cealed in an administrative ofﬁce, otherwise not
involved in the study and physicians and the course
instructors used a central telephone service to obtain
group allocation.
Intervention for both groups
All patients followed an asthma-speciﬁc educa-
tion, which aimed to empower asthma patients to
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better self-management. The programme con-
sisted of group and individual education held by
experienced asthma trainers (C.S., B.S.) at the
Centre for Interdisciplinary Patient Education of
the University Hospital of Zurich, Switzerland.
The modules addressed three main dimensions:
(1) Knowledge (pathophysiology of asthma, ben-
eﬁts and side effects of drugs), (2) Skills [inhalation
technique, self-monitoring with peak expiratory
ﬂow (PEF) and symptom diaries], (3) Behaviour
(interpretation of self-monitoring and appropriate
action in case of asthma deterioration based on a
written action plan that used a trafﬁc light scheme
to indicate a stable situation or worsening). The
actions recommended to patients were:
∙ To continue with their usual daily asthma
medication if PEF was ⩾80% and they had no
symptoms (green light).
∙ To double the dose of inhaled corticosteroids or
combination therapy if PEF was <80% and/or
symptoms started to get worse over at least two
days (yellow light).
∙ To start oral prednisone (50 mg daily over ﬁve to
seven days) in addition to increased inhalation
and contact their physician if PEF was <50%
and/or symptoms were shortness of breath
during daily activities, awakenings during night,
or rescue bronchodilator showed diminished
response (orange-red light).
∙ To immediately contact a physician or call
emergency if PEF was <30% (dark red light).
Disease non-speciﬁc self-management training
for intervention group
The intervention group participated in the
Zurich Resource Model (ZRM®) training (www.
zrm.ch) that is based on cognitive-behavioural
theory. It focuses on self-aspects and aims to
increase resources and self-efﬁcacy in daily life.
ZRM training also tries to enhance body aware-
ness. Patients attended the two-day, group-based
ZRM training and two refresher sessions of 2 h
after 4 and 12 weeks. Two experienced ZRM
trainers (S.B., B.H.) offered the training following
the ZRM Training Manual (Storch and Krause,
2002). The heuristic model entailed and chosen in
the Zurich Resource Model (ZRM®) training is
the ‘Rubicon’ model. The model presents a
sequence of individual steps leading towards sys-
tematic goal-realizing actions. The term ‘Rubicon’
is in reference to the decisive moment in 49 BC
when Julius Caesar, after much deliberation,
decided to cross the river Rubicon with his sol-
diers, declaring ‘alea jacta est’ (The die is cast).
The Rubicon model is, of course, not a theory to
explain how wars are started, but it represents the
basic problem in motivation psychology, namely,
that there is a metaphorical Rubicon to cross
between an intention to act and the action.
The ZRM training consists of ﬁve phases that
extend over the main and refresher sessions.
(1) Activation of personal resources. A set of
pictures eliciting positive feelings is shown to
patients followed by a question about which
pictures evoke positive somatic responses
such as pleasant body feeling.
(2) Goal setting. Action-oriented personal goals
are discussed in small groups and written
down together with potential means to
achieve them and potential barriers.
(3) Identiﬁcation of individual resources. Indivi-
dual resources to achieve personal goals are
identiﬁed, which is enhanced by embodiment
techniques with posture, gesture and facial
expressions. Embodiment acknowledges that
the mind is embedded in the body and
empirical evidence shows multiple ways in
which the body inﬂuences mental processes,
emotion and behaviour. Participants develop
their individual goal-related embodiment,
which subjectively expresses the emotion and
behaviours that facilitates goal reaching.
(4) Action. The goal-oriented use of identiﬁed
resources in different situations is practiced in
role plays. A particular emphasis is put on the
identiﬁcation of ‘warning signals’ for unwanted
emotions or behaviours and on strategies to
stop them by positive self-instructions and
thought-stop techniques.
(5) Transfer into daily life. The results of the
ZRM training are revised and discussed with
the aim to integrate changes into daily life.
A detailed description of the training methods
and procedures is available on request from the
authors and has been published elsewhere (Storch
and Krause, 2002, Storch, 2004).
Outcome measures
Our primary outcomemeasures were adherence to
self-monitoring and adherence to the individualized
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action plan over the ﬁrst three months. We
deﬁned, a priori, adherence to self-monitoring as
measurement and recording of PEF and symptoms
on at least four of seven days on average over the
study period. Thus, for three months (90 days), we
deﬁned patients to be adherent to self-monitoring
if they registered their symptoms and/or peak-ﬂow
at least once per day on 51 of the 90 days. Patients
were instructed to monitor PEF and symptoms
daily and to complete the asthma diary. For PEF
monitoring, we instructed participants how to use
the microlife® asthma monitor device (Micro
Direct Inc. 803, Lewiston, ME, USA, www.micro-
direct.com). The microlife® has a memory that
stores up to 240 peak ﬂow measurements that
allowed us, as a measure of compliance, to check
whether patients completed the diary correctly.
For symptom monitoring, we instructed patients
how to rate the symptom scores in the asthma
diary for dyspnoea, cough and sputum production
on a scale from 0 no symptoms, 1 mild symptoms, 2
moderate symptoms and 3 severe symptoms.
We deﬁned adherence to the action plan if 80%
of actions taken by patients to adjust their medi-
cation were correct according to the action plan. A
correct action was deﬁned as the action that was
speciﬁed in the action plan for the respective
description of the trafﬁc light scheme (see above).
Incorrect actions included adjustments to medica-
tion when it was not needed (green light), no
adjustments to medication when it was recom-
mended (yellow, orange and red zone) and no
immediate contact to a health-care professional in
the case of emergency (red zone). When patients
adjusted their medication, although there was no
need to (green light), we considered it a non-
correct action. Patients recorded every day on
their asthma diary whether and how they adjusted
their medication. As this outcome depended on
adherence to self-monitoring, we only assessed this
outcome for patients with adherence to self-
monitoring as deﬁned above.
Patient-reported self-efﬁcacy
We used the validated German version of the
widely used general perceived self-efﬁcacy scale
that measures an individual’s perception of his or
her ability to perform an action (Schwarzer and
Born, 1977; Schwarzer, 1992) The scale includes
10 items that are answered on a four-point Likert-
type scale.
Patient-reported self-regulation
We used the validated Volitional Components
Inventory (Kuhl and Fuhrmann, 1998). Speciﬁc
issues addressed include the development of self-
control and self-regulation. We focused on domains
of the Volitional Components Inventory that we
deemed most relevant for the scope of our trial: The
attention control domain that captures to what
extent personal goals meet personal needs, the self-
motivation domain, the intention control domain
that measures the capability of being action oriented,
and the impulse control domain that captures how
the expectations of other people meet a person’s
own goal and intentions.
Sample size
We based our sample size on the primary out-
come ‘adherence to the action plan’ at three
months. According to published data (Adams
et al., 2001; Toelle and Ram, 2004), we expected
that 30% of control group patients would adhere
to the action plan as deﬁned above. For patients in
the intervention group we expected an adherence
of 75%. To detect the difference of 45% between
the groups, we needed a total sample size (both
groups) of 46 patients at a signiﬁcance level of 0.05
(two-sided) and a power of 80%. Assuming that
15% of the patients would not adhere to self-
motoring and are thus not eligible for the analysis
and assuming a dropout rate of 10% during the
ﬁrst three months, the required sample size
increased to 60 patients.
Statistical analysis
We included all patients in the analysis accord-
ing to their randomization (intention-to-treat) if
they started the unspeciﬁc asthma patient educa-
tion. We used medians [interquartile ranges
(IQR)] to describe non-normally distributed data
and means [standard deviation (SD)] for normally
distributed data. We used the non-parametric
Wilcoxon rank-sum test to compare adherence
with self-monitoring and with the action plan and
logistic regression analysis with adjustment for
baseline imbalances to compare the odds for
adherence with self-monitoring as deﬁned above.
To compare groups for secondary outcomes, we
used linear regression analysis, again with the
adjustment for baseline imbalances. We performed
all analyses using STATA for Windows 10.1 (Stata
Corporation).
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Results
Patients
We assessed 72 patients for eligibility between
October and December 2008. Five patients
did not meet the inclusion criteria and six refused
to participate. We randomized 61 patients to
the intervention (n= 30) and control group
(n= 31), respectively. One patient in the control
group discontinued owing to relocation shortly
after randomization and did not start the educa-
tion at all. As we did not want to impute all
follow-up data for this single patient, we analysed
the data of 60 patients (Figure 1). Despite stratiﬁed
randomization, control patients were younger,
mostly male and reported better asthma control
compared with the intervention group (Table 1).
We therefore adjusted the analyses for these
imbalances.
Adherence to self-monitoring
Table 2 shows that patients of both groups
recorded their PEF and symptom monitoring on
most days. Both groups showed high adherence to
self-monitoring over three months [27 patients
(90.0%) in intervention and 25 patients (83.3%) in
control group, P= 0.65]. Patients with the inter-
vention did not show signiﬁcantly better adher-
ence to self-monitoring [unadjusted odds ratio 1.80
(95% CI 0.39–8.32, P= 0.45), and adjusted odds
ratio 1.28 (0.24–6.78), P= 0.78].
Assessed for eligibility (n= 72)
Excluded (n= 11)
Not meeting inclusion criteria
(n= 5)
Refused to participate
(n= 6)
Analyzed (n=30)
Lost to follow-up
during three months study period
(n=0)
Allocated to intervention group
(n=30)
Lost to follow-up
during three months study period
(n= 1)
Allocated to control group 
(n= 31)
Analyzed (n= 30)
Randomized (n=61)
Figure 1 Flow diagram
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Adherence to action plan
Very few patients required an adjustment of
their medication according to their PEF and
symptom recordings as expressed by the average
number of days requiring action (Table 2).
Patients with the ZRM training adjusted their
medication more frequently than patients in the
control group, but the difference was not statisti-
cally signiﬁcant (P= 0.20). The average number of
days with adjustment of medication was sub-
stantially higher than the average number of days
where an adjustment was necessary. As a con-
sequence, only few patients made adjustments to
their medication according to their action plan
either because they did not act when recom-
mended, or more frequently, because they made
adjustments, although this was not indicated. On
average, a median of 11% (IQR 0–56) of actions
taken by control group patients were correct
compared with 20% (IQR 0–37) of actions in the
intervention group (P-value for difference= 0.92).
Because the number of days with action
required by the action plan was low, and conse-
quently a proportion of correct actions could not
be calculated in any sensible way, we could not
compare the proportion of patients with adher-
ence to the action plan (80% of actions taken by
patients to adjust their medication were correct).
Patient-reported self-efﬁcacy
Patients with the disease unspeciﬁc behavioural
training showed signiﬁcantly improved self-
efﬁcacy after three months compared with con-
trol group patients. The adjusted difference (linear
regression analysis) between groups was 2.31
(95%CI 0.31–4.31) points in the general perceived
self-efﬁcacy scale, P= 0.024 (Table 3).
Patient-reported self-regulation
Both groups showed improvements in self-
regulation after three months. Improvements
Table 1 Baseline characteristics
Asthma therapy before randomization n=61
None or SABA on demand only 13 (21.3%)
ICS plus LABA/SABA 41 (67%)
LTRA 3 (4.9%)
LABA without ICS 3 (4.9%)
Patients with peak ﬂow measuring before randomization 29 (47.5%)
Randomization Patient education
(n= 31)
Patient education+ZRM
(n=30)
Age (SD) 33.7 (10.0) 43.2 (14.9)
Gender [male/female (%)] 14/17 (45/55) 11/19 (37/63)
Years since diagnosis [years (SD)] 15.1 (9.5) 17.7 (14.9)
Peak ﬂow baseline [L/min (SD)] 504 (117) 444 (133)
Patients with
>2-day symptoms/week (%) 13 (43.3) 14 (48.3)
>2-night symptoms/month (%) 6 (20.0) 9 (31.0)
Limitation in daily activities (%) 12 (40.0) 14 (48.3)
Use of rescue medication (%) in last month 6 (20.0) 14 (48.3)
Self-efﬁcacy 29.8 (4.7) 28.7 (4.2)
Self-regulation
Attention controla 10.6 (2.3) 10.3 (2.7)
Self motivationb 10.1 (2.6) 10.0 (2.8)
Intention controlc 11.1 (2.5) 10.4 (2.7)
Impulse controld 12.1 (3.1) 10.8 (3.7)
SABA= short acting betaagonist; ICS= inhaled corticosteroids; LABA= long acting betaagonsist; LRTA= leucotriene
receptor antagonist; ZRM=Zurich Resource Model.
a Scale 1 of Volitional Components Inventory.
b Scale 2 of Volitional Components Inventory.
c Scale 7 of Volitional Components Inventory.
d Scale 10 of Volitional Components Inventory.
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were larger but not statistically signiﬁcant in
patients with the ZRM training (Table 3).
Discussion
Main results
The primary ﬁnding of this randomized con-
trolled study is that the disease non-speciﬁc self-
management training did not increase adherence
to asthma self-management with an action plan.
This may be because the intervention was not
effective, but it is more likely because of the fact
that participants in both groups experienced very
few days that warranted adjustment of treatment.
With much lower than expected event rates, cap-
turing a difference in groups became unlikely.
However, we observed a signiﬁcant increase in
self-efﬁcacy, which is a critical feature of behaviour
change processes in chronic diseases (Lorig and
Holman, 2003).
Adherence to self-management
In asthma, to do the right thing at the right time
reduces morbidity and even mortality (Gibson
et al., 2003; Partridge et al., 2006). However,
data show that patients wait too long and do not
react adequately with deterioration (Partridge
et al., 1997; Steurer-Stey et al., 2005). Patients in
both groups showed better adherence to self-
monitoring with PEF and symptoms than usually
reported (Verschelden et al., 1996). One potential
reason is that a team trained and experienced in
evidence-based asthma education educated all
patients. It is likely that this education improved
patients’ inner motivation to be in control in both
groups and prompted patients to better adherence,
making the detection of an additional effect
difﬁcult.
Patients in both groups experienced few days of
worsening that warranted an adjustment of treat-
ment. Several reasons may explain this. It is pos-
sible that our tools used for self-assessment (peak
ﬂow and symptom logs) underestimated symptoms
so that treatment was not adjusted, although it may
have been necessary in some situations. Perhaps,
more pertinently, the asthma education included
an optimization of asthma treatment according to
guidelines. This not only could have prompted
patients to better adherence, but substantially also
affect asthma control and hence reduced the
number of occasions on which adjustment of
Table 2 Adherence to self-monitoring and to action plan during the ﬁrst three months
Patient
education plus
ZRM (n= 30)
Patient
education alone
(control) (n=30)
P valuea
Adherence to self-monitoring
Percentage of days with peak ﬂow measurements
[median (IQR)]b
91 (78–97) 82 (70–93) 0.13
Percentage of days with symptom recordings
[median (IQR)]c
99 (42–100) 93 (41–99) 0.38
Patients (%) with adherence to self-measurementd 27 (90.0) 25 (83.3) 0.65
Adherence to action plan
Number of days with action required by peak ﬂow
monitoring [median (IQR)]
7 (0–44) 1 (0–12) 0.39
Number of days with action required by symptom
monitoring [median (IQR)]
8 (2–17) 3 (0–9) 0.17
Number of days with action [median (IQR)] 32 (10–55) 8 (0–31) 0.20
Percentage of correct actions among all actions
[median (IQR)]
20 (0–37) 11 (0–56) 0.92
Patients with asthma control therapy 90% 93% 0.68
ZRM=Zurich Resource Model.
aWilcoxon rank sum test or χ2 test.
b 178 mornings and evening measurements possible over three months.
c 90 days.
d Recording of PEF and symptoms, on average, at least four of seven days.
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treatment was indicated. Low rates of adjustment
of medications as recommended by the action plan
have been reported earlier (Adams et al., 2001)
and this is still not fully understood. An explana-
tion is that patients modify their interpretation of
the action plan on the basis of personal experi-
ences and perceptions of asthma (Toelle and Ram,
2004). To gain more insights into these processes
and to understand what inﬂuences the patients’
attitude towards self-initiated treatment changes,
it may be necessary to complement trial evidence
with qualitative research (Douglass et al., 2002).
Self-efﬁcacy and self-regulation
Self-regulation broadly denotes the processes
through which people bring their thoughts, feel-
ings, and behaviour in line with goals (Kuhl and
Fuhrmann, 1998; Clark et al., 2001). Self-efﬁcacy,
an individual’s perception of his or her ability to
perform an action and in health terms a patient’s
belief regarding the ability for certain health
behaviours, is a critical ingredient in the self-
management process (Bandura, 1977b; 1997; 2001;
Holman and Lorig, 1992; Lorig et al., 2001a; Barlow
et al., 2002; Lorig and Holman, 2003; Creer, 2008).
The task entailed in the ZRM training is to
identify and to understand how new desirable
behaviour can be successfully implemented in a
person’s daily life. It analyses the basic problem in
motivation psychology, namely, that there is a
metaphorical Rubicon to cross between an inten-
tion to act and the action. In clinical work, we
often realize that the extent to which patients
acquire and apply self-management depends not
mainly on their knowledge and information about
the disease but on disease-unspeciﬁc factors and
their general ability to transform an intention to
act into the action, the crossing of the ‘Rubicon’.
Despite signiﬁcantly improved self-efﬁcacy and
self-regulation, patients with the ZRM training did
not show better adherence to the action plan after
three months. The higher self-efﬁcacy and self-
regulation may be due to an initial rise in self-
efﬁcacy that is not maintained and does not translate
into better adherence to the action plan. It may also
reﬂect that patients start thinking, as a consequence
of the ZRM training, about what they want to do but
have not yet succeeded to do so. Behavioural chan-
ges in chronic conditions may need time to translate
into health beneﬁts, and therefore our study period
was likely to be too short. Another explanation for
the gap between improved self-efﬁcacy and unim-
proved adherence may be that adherence to
self-management takes into account different self-
aspects, and therefore non-adherence, an irrational
act from the doctor’s view, may be a rational action
from a patient’s perspective (Creer, 2008). We may
have to refocus our perspective more towards an
understanding of how patients take decisions in the
self-management process.
Table 3 Patient-reported self-efﬁcacy and self-regulation
Change from baseline to
follow-up
Difference between
groups
Adjusted difference
between groupsa
Patient
education
Patient
education+ZRM
Self-efﬁcacy scale scoresafter
three months
0.93 (3.36) 3.50 (4.08) 2.57 (0.62–4.52), P= 0.011 2.31 (0.31–4.31), P=0.024
Self-regulation scores after
three months
Attention controlb 0.93 (2.12) 1.50 (2.94) 0.57 (−0.77–1.91), P=0.40 0.30 (−0.91–1.51), P=0.62
Self motivationc 0.48 (2.03) 0.87 (2.71) 0.39 (−0.86–1.63), P=0.54 0.08 (−1.10–1.26), P=0.89
Intention controld 0.34 (2.50) 1.73 (2.48) 1.39 (0.09–2.69), P= 0.04 0.95 (−0.36–2.25), P=0.15
Impulse controle 1.72 (2.30) 1.60 (3.84) −0.12 (−1.78–1.53), P=0.88 −0.76 (−2.31–0.78), P=0.33
ZRM=Zurich Resource Model.
a Adjusted for age, gender and baseline peak expiratory ﬂow (PEF).
b Scale 1 of Volitional Components Inventory.
c Scale 2 of Volitional Components Inventory.
d Scale 7 of Volitional Components Inventory.
e Scale 10 of Volitional Components Inventory.
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Strength and limitations of our study
A strength of this study is our adherence to
methodological standards for randomized trials
and an explicit deﬁnition of our interventions.
A limitation is the good asthma control during the
study period as a consequence of our intensive con-
trol intervention that clearly exceeded usual asthma
care. The power calculation was based on detecting a
large effect as a consequence; the sample size was
too small to detect small changes. In addition, self-
reported symptoms may have contributed to smaller
between-group differences as non-differential mea-
surement error attenuates effect estimates towards
the null. Finally, we could not determine whether
self-monitoring or adherence changed from before
randomization to any time point during follow-up
because we did not have a run-in period before
randomization and because we did not want to rely
on self-reported data based on the recall of patients.
Conclusion
Unspecific self-management training did not increase
asthma self-management adherence in short term.
Further research should try to open the ‘black box’ of
patient self-management by studying the processes of
self-management from the patients’ perspective.
Acknowledgements
The authors thank Mrs B. Bichsel von Arb for the
study coordination. They also thankMrs K. Studer
for data collection.
Conﬂicts of Interest
Claudia Steurer-Stey gives lectures for AstraZeneca,
Glaxo Wellcome and Merck Scharp & Dome,
Boehringer Ingelheim, Pﬁzer and Novartis. The
second author is employed by Sandwell and West
Birmingham CCG. Milo Puhan, Johann Steurer,
Barbara Steffen-Bürgi, Susanne Benz, Barbara
Hobi: none. Maja Storch together with Frank
Krause developed the Zurich Resource Model.
She is director of the ZRM research unit at the
University of Zurich.
Authors’ contribution
All authors made a substantial contribution to this
manuscript, that is, conception, design and drafting.
Funding
The study was supported by an unrestricted grant
from AstraZeneca Switzerland for research in
patient education and asthma. K. Studer received
salary support from the grant.
References
Adams, R.J., Smith, B.J. and Rufﬁn, R.E. 2001: Patient
preferences for autonomy in decision making in asthma
management. Thorax 56, 126–32.
Bandura, A. 1977a: Self-efﬁcacy: toward a unifying theory of
behavioral change. Psychological Review 84, 191–215.
Bandura, A. and Adams, N.E. 1977b: Analysis of self-efﬁcacy
theory of behavioral change. Cognitive Therapy and
Research 1, 287–304.
Bandura, A. 1997: Self-efﬁcacy the exercise of control.
New York, NY: W H Freeman/Times Books/Henry Holt
& Co.
Bandura, A. 2001: Social cognitive theory: an agentic
perspective. Annual Review of Psychology 52, 1–26.
Barlow, J., Wright, C., Sheasby, J., Turner, A. and
Hainsworth, J. 2002: Self-management approaches for
people with chronic conditions: a review. Patient Education
and Counseling 48, 177–87.
Bodenheimer, T., Lorig, K., Holman, H. and Grumbach, K.
2002: Patient self-management of chronic disease in
primary care. Journal of the American Medical Association
288, 2469–75.
The British Thoracic Society. 2003: British guideline on the
management of asthma. Thorax 58(Suppl. 1), i1–94.
Calfee, C.S., Katz, P.P., Yelin, E.H., Iribarren, C. and Eisner,
M.D. 2006: The inﬂuence of perceived control of asthma on
health outcomes. Chest 130, 1312–18.
Clark, N.M., Gong, M. and Kaciroti, N. 2001: A model of self-
regulation for control of chronic disease. Health Education
& Behavior 28, 769–82.
Clark, N.M. and Partridge, M.R. 2002: Strengthening
asthma education to enhance disease control. Chest
121, 1661–69.
Creer, T.L. 2008: Behavioral and cognitive processes in the self-
management of asthma. Journal of Asthma 45, 81–94.
Douglass, J., Aroni, R., Goeman, D., Stewart, K., Sawyer, S.,
Thien, F. and Abramson, M. 2002: A qualitative study
of action plans for asthma. British Medical Journal 324,
1003–1005.
Gibson, P.G. and Powell, H. 2004: Written action plans for
asthma: an evidence-based review of the key components.
Thorax 59, 94–99.
Gibson, P.G., Powell, H., Coughlan, J., Wilson, A.J.,
Abramson, M., Haywood, P., Bauman, A., Hensley, M.J.
and Walters, E.H. 2003: Self-management education and
regular practitioner review for adults with asthma.Cochrane
Database of Systematic Reviews, CD001117.
Primary Health Care Research & Development 2015; 16: 32–41
40 Claudia Steurer-Stey et al.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1463423613000480
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 14:11:02, subject to the Cambridge Core terms of use, available at
Global Initiative for Asthma (GINA). 2006: From the Global
Strategy for Asthma Management and Prevention.
Available at: http://www.ginasthma.org/
Holman, H. and Lorig, K. 1992: Perceived self-efﬁcacy in self-
mnagement of chronic disease. In Schwarzer, R., editors,
Self-efﬁcacy: thought control of action, pp. 305–323.
Washington, DC: Hemisphere Publishing Corp.
Jones, A., Pill, R. and Adams, S. 2000: Qualitative study of
views of health professionals and patients on guided self
management plans for asthma. British Medical Journal 321,
1507–10.
Kuhl, J. and Fuhrmann, A. 1998: Decomposing self-regulation
and self-control: the volitional components inventory. In
Heckhausen, J., Dweck, C.S. editors, Motivation and self-
regulation across the life span, pp. 15–49. New York, NY,
US: Cambridge University Press.
Lorig, K.R. andHolman, H. 2003: Self-management education:
history, deﬁnition, outcomes, and mechanisms. Annals of
Behavioral Medicine 26, 1–7.
Lorig, K.R., Ritter, P., Stewart, A.L., Sobel, D.S., Brown, B.W.
Jr, Bandura, A., Gonzalez, V.M., Laurent, D.D. and
Holman, H.R. 2001a: Chronic disease self-management
program: 2-year health status and health care utilization
outcomes.Medical Care 39, 1217–23.
Lorig, K.R., Sobel, D.S., Ritter, P.L., Laurent, D. and Hobbs, M.
2001b: Effect of a self-management program on patients with
chronic disease. Effective Clinical Practice 4, 256–62.
National Heart Lung and Blood Institute. 1991: Expert Panel
Report 1: Guidelines for the diagnosis and management of
asthma. U.S. Department of Health and Human Services,
National Institutes of Health. Available at: http://www.nhlbi.
nih.gov/guidelines/index.htm
Partridge, M.R., Latouche, D., Trako, E. and Thurston, J.G.
1997: A national census of those attending UK accident and
emergency departments with asthma. The UK National
Asthma Task Force. Journal of Accident & Emergency
Medicine 14, 16–20.
Partridge, M.R., Van Der Molen, T., Myrseth, S.E. and
Busse, W.W. 2006: Attitudes and actions of asthma patients
on regular maintenance therapy: the INSPIRE study. BMC
Pulmonary Medicine 6, 13.
Schwarzer, R. editors. 1992: Self-efﬁcacy: thought control of
action. Washington, DC: Hemisphere.
Schwarzer, R. and Born, A. 1977: Assessment of general
perceived self-efﬁcacy in thirteen cultures.World Pschology
3, 177–90.
Steurer-Stey, C., Fletcher, M., Vetter, W. and Steurer, J. 2006:
Patient education in asthma: a survey of physicians’ knowl-
edge of the principles and implementation of self manage-
ment in practice. Swiss Medical Weekly 136, 561–65.
Steurer-Stey, C., Grob, U., Jung, S., Vetter, W. and Steurer, J.
2005: Education and a standardized management protocol
improve the assessment and management of asthma in the
emergency department. Swiss Medical Weekly 135, 222–27.
Storch, M. 2004: Resource-activating selfmanagement with the
Zurich Resource Model (ZRM). European Psychotherapy
5, 27–64.
Storch, M. and Krause, F. 2002: Selbstmanagement – ressource-
norientiert. Grundlagen undTrainingsmanual für dieArbeit mit
dem Zürcher RessourcenModell (Self management – ressource
oriented theoretical background an training manual of the
Zurich Resource Model (ZRM®). Auﬂ. Huber: Bern.
Toelle, B.G. and Ram, F.S. 2004: Written individualised
management plans for asthma in children and adults.
Cochrane Database of Systematic Reviews 1, 1–22.
Verschelden, P., Cartier, A., L'archeveque, J., Trudeau, C. and
Malo, J.L. 1996: Compliance with and accuracy of daily self-
assessment of peak expiratory ﬂows (PEF) in asthmatic
subjects over a three month period. European Respiratory
Journal 9, 880–85.
Primary Health Care Research & Development 2015; 16: 32–41
Asthma self-management adherence 41
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1463423613000480
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 14:11:02, subject to the Cambridge Core terms of use, available at
